Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19
Latest Information Update: 05 Oct 2021
At a glance
- Drugs Aldesleukin (Primary)
- Indications COVID 2019 infections; SARS-CoV-2 acute respiratory disease
- Focus Therapeutic Use
- Acronyms LILIADE-COVID
Most Recent Events
- 01 Oct 2021 Status changed from active, no longer recruiting to completed.
- 08 Apr 2021 Planned End Date changed from 23 Feb 2021 to 23 Apr 2021.
- 08 Apr 2021 Status changed from recruiting to active, no longer recruiting.